Post-earnings recap
Reported
Mon, Nov 7, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's strong EPS performance, exceeding expectations by over 30%, has led to a notable stock increase of 7.56%. Investors reacted positively to the earnings surprise, indicating confidence in the company's operational strategies. However, the lack of revenue details and future guidance may leave some investors cautious about long-term growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +30.68% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook regarding their earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They highlighted ongoing efforts to improve operational efficiency.